Profiling SLCO and SLC22 Genes in the NCI-60 Cancer Cell Lines to Identify Drug Uptake Transporters

Molecular Cancer Therapeutics - United States
doi 10.1158/1535-7163.mct-08-0539
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

A Map of Mobile DNA Insertions in the NCI-60 Human Cancer Cell Panel

Mobile DNA
Molecular Biology
2016English

Distinct Genes Related to Drug Response Identified in ER Positive and ER Negative Breast Cancer Cell Lines

PLoS ONE
Multidisciplinary
2012English

Genomic Profiling of Biliary Tract Cancer Cell Lines Reveals Molecular Subtypes and Actionable Drug Targets.

iScience
Multidisciplinary
2019English

Paralog Buffering Contributes to the Variable Essentiality of Genes in Cancer Cell Lines

PLoS Genetics
EvolutionEcologyGeneticsMolecular BiologyCancer ResearchSystematicsBehavior
2019English

Non-Small-Cell Lung Cancer Cell Lines A549 and NCI-H460 Express Hypoxanthine Guanine Phosphoribosyltransferase on the Plasma Membrane

OncoTargets and Therapy
OncologyPharmacology
2017English

Recombination Phenotypes of the NCI-60 Collection of Human Cancer Cells

BMC Molecular Biology
Molecular Biology
2011English

From Drug Response Profiling to Target Addiction Scoring in Cancer Cell Models

DMM Disease Models and Mechanisms
ImmunologyMolecular BiologyBiochemistryMicrobiology NeuroscienceMedicineGenetics
2015English

Tissue Microarray Profiling of Cancer Specimens and Cell Lines: Opportunities and Limitations

Laboratory Investigation
Forensic MedicinePathologyCell BiologyMolecular Biology
2001English

Drug Sensitivity in Cancer Cell Lines Is Not Tissue-Specific

Molecular Cancer
Cancer ResearchOncologyMolecular Medicine
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy